Heimdall Insights

Global Venous Leg Ulcer and Deep Vein Thrombosis Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Venous Leg Ulcer and Deep Vein Thrombosis Market was valued at $5.4 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.3% CAGR, to an estimated market size of $7.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global market for Venous Leg Ulcer (VLU) and Deep Vein Thrombosis (DVT) includes the diagnosis, treatment, and management of chronic wounds and blood clots in the deep veins. The scope encompasses pharmaceutical therapies (anticoagulants, thrombolytics), medical devices (compression therapy, advanced wound dressings, intermittent pneumatic compression), and surgical interventions (endovascular procedures, stents, and catheters). It excludes general wound care not specifically related to venous insufficiency.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Venous Leg Ulcer and Deep Vein Thrombosis Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Segments

  • Compression Therapy
  • Pharmaceuticals
  • Advanced Wound Dressings
  • Surgical & Interventional Devices